Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period

Original article
Çınar HU, İnce Ö, Çelik B, Saltabaş F, Özbek M
Swiss Med Wkly. 2020;150:w20302

The case presented here represents an “incidental” sampling of a lung infected with SARS-CoV-2, as a result of surgery for lung cancer at a time when the lung infection did not produce symptoms. This gave the opportunity to examine the pathology of COVID-19 pneumonia during the incubation period.

Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?

Viewpoint
Negro F
Swiss Med Wkly. 2020;150:w20249

The pathogenesis of COVID-19 is currently believed to proceed via both directly cytotoxic and immune-mediated mechanisms. An additional mechanism facilitating viral cell entry and subsequent damage may involve the so-called antibody-dependent enhancement (ADE).

Non-invasive diagnosis of liver steatosis: ready for primetime?

Viewpoint
Goossens N
Swiss Med Wkly. 2019;149:w20108

The formal diagnosis of hepatic steatosis relies on liver histology based on a liver biopsy, which is an invasive procedure that is not required in the majority of cases. Due to the high prevalence of liver steatosis, in particular in the context of an increase in NAFLD incidence, there has been renewed interest in use of non-invasive tools to assess the presence of liver disease.

Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience

Original article
Baumeler S, Jochum W, Neuweiler J, Bergamin I, Semela D
Swiss Med Wkly. 2019;149:w20077

Accurate diagnosis and staging of non-alcoholic fatty liver disease are essential for its management. Controlled attenuation parameter is a new noninvasive measurement made during transient elastography to assess liver steatosis.

Hepatic manifestations of Wilson’s disease: 12-year experience in a Swiss tertiary referral centre

Original article
Vieira Barbosa J, Fraga M, Saldarriaga J, Hiroz P, Giostra E, Sempoux C, Ferenci P, Moradpour D
Swiss Med Wkly. 2018;148:w14699

Wilson’s disease is an inherited disorder of hepatic copper metabolism, leading to the accumulation of copper in the liver as well as the brain, cornea and other organs.

Motivational interviewing increases autopsy rates

Original article
Rosenberg I, Gierer B, Flury R, Battegay E, Balmer PE
Swiss Med Wkly. 2018;148:w14679

Autopsies are a crucial source of medical knowledge. Autopsy rates have decreased in Switzerland and many other countries. Communication between clinicians and the deceased’s sceptical relatives is crucial to obtain autopsy permission.

Synovial sarcoma: when epigenetic changes dictate tumour development

Review article: Biomedical intelligence
Riggi N, Cironi L, Stamenkovic I
Swiss Med Wkly. 2018;148:w14667

Synovial sarcoma accounts for 10 to 20% of all soft tissue sarcomas in the adolescent and young adult population and is the most common soft tissue sarcoma after rhabdomyosarcoma. Elucidation of the pathogenesis is needed to develop effective, mechanism-based therapeutic strategies.

Recommendations for genetic testing and counselling after sudden cardiac death: practical aspects for Swiss practice

Review article: Biomedical intelligence
Medeiros Domingo A, Bolliger S, Gräni C, Rieubland C, Hersch D, Asatryan B, Schyma C, Saguner A, Wyler D, Bhuiyan Z, Fellman F, Osculati AM, Ringger R, Fokstuen S, Sabatasso S, Wilhelm M, Michaud K, Swiss Working Group on Sudden Cardiac Death
Swiss Med Wkly. 2018;148:w14638

Genetic testing can reveal substrates for cardiomyopathies and channelopathies, as well as aortic diseases and premature atherosclerosis, which may explain some sudden cardiac deaths.

New treatment for non-Hodgkin B-cell lymphomas with a special focus on the impact of junctional adhesion molecules

Review article: Biomedical intelligence
Imhof BA, Matthes T
Swiss Med Wkly. 2017;147:w14487

B-cell non-Hodgkin lymphomas are are among the six most common cancer types in Switzerland. Five-year survival is approximately 55–75%.

Diagnosis and assessment of renal fibrosis: the state of the art

Review article: Biomedical intelligence
Berchtold L, Friedli I, Vallée JP, Moll S, Martin PY, de Seigneux S
Swiss Med Wkly. 2017;147:w14442

Evaluation of interstitial fibrosis is crucial to the assessment of prognosis and to guide therapy for most kidney diseases. However, how best to measure kidney fibrosis remains uncertain.

Verpassen Sie keinen Artikel!

close